Skip to content

Advertisement

  • Correction
  • Open Access

Correction to: Hormonal contraceptives and risk of ischemic stroke in women with migraine: a consensus statement from the European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESC)

  • 1Email author,
  • 2,
  • 3,
  • 4,
  • 5,
  • 6,
  • 7, 8,
  • 9,
  • 10, 11,
  • 12,
  • 13,
  • 14, 15,
  • 16,
  • 17,
  • 18, 19 and
The Journal of Headache and PainOfficial Journal of the "European Headache Federation" and of "Lifting The Burden - The Global Campaign against Headache"201819:81

https://doi.org/10.1186/s10194-018-0912-9

  • Received: 3 September 2018
  • Accepted: 3 September 2018
  • Published:

The original article was published in The Journal of Headache and Pain 2017 18:108

Correction

Following the publication of this article [1], the authors noticed that they incorrectly reported the Absolute risk of ischemic stroke in women aged 20 to 44 years in relation to the use of hormonal contraception and migraine status due to a miscalculation. They apologize for this misreported result.

The correct version of Table 4 has been included in this correction.
Table 4

(Revised) Absolute risk of ischemic stroke in women aged 20 to 44 years in relation to the use of hormonal contraception and migraine status

 

No migraine

Migraine with aura

Migraine without aura

Without hormonal contraception

2.5/100,000

5.9/100,000

4.0/100,000

With hormonal contraception

6.3/100,000

14.5/100,000

10.0/100,000

Considering women with migraine with aura, the risk of ischemic stroke in those young women who do not use HC is 5.9/100,000 per year whereas the same risk among those young women who use HC is 14.5 /100,000 per year

Considering women with migraine without aura, the risk of ischemic stroke in those young women who do not use HC is 4.0/100,000 per year whereas the same risk among those young women who use HC is 10.0/100,000 per year

Notes

Declarations

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

Authors’ Affiliations

(1)
Department of Applied Clinical Sciences and Biotechnology, University of L’Aquila, L’Aquila, Italy
(2)
Department of Gynecology, Clinic for Reproductive Endocrinology, University Hospital, Zürich, Switzerland
(3)
Department of Neurology, Bispebjerg Hospital and University of Copenhagen, Copenhagen, Denmark
(4)
Department of Obstetrics and Gynecology, University Hospital of Basel, Basel, Switzerland
(5)
Université Paris-Saclay, University Paris-Sud, UVSQ, CESP, Inserm UMRS1018, Orsay, France
(6)
Institute of Public Health, Charité – Universitätsmedizin Berlin, Berlin, Germany
(7)
Headache Medical Center Seilerstaette Linz, Linz, Austria
(8)
Department of Geriatric Medicine Ordensklinikum Linz, Linz, Austria
(9)
Department of Obstetrics & Gynaecology, Rigshospitalet, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark
(10)
Centre for Neuroscience & Trauma, BICMS, Barts and the London School of Medicine and Dentistry, London, UK
(11)
Barts Sexual Health Centre, St Bartholomew’s Hospital, London, UK
(12)
Division of Vascular Medicine and Pharmacology, Department of Internal Medicine, Erasmus Medical Center Rotterdam, Rotterdam, The Netherlands
(13)
Department of Neurology, Aeginition Hospital, National and Kapodistrian University of Athens, Athens, Greece
(14)
Research Centre for Reproductive Medicine, Gynecological Endocrinology and Menopause, IRCCS S. Matteo Foundation, Department of Clinical, Surgical, Diagnostic and Pediatric Sciences, University of Pavia, Pavia, Italy
(15)
University Consortium for Adaptive Disorders and Head Pain (UCADH), University of Pavia, Pavia, Italy
(16)
Department of Medicine, University of Thessaly, Larissa, Greece
(17)
Department of Haematology, Oslo University Hospital and University of Oslo, Oslo, Norway
(18)
Department of Clinical and Molecular Medicine, Sapienza University of Rome, Rome, Italy
(19)
Regional Referral Headache Centre, Sant’Andrea Hospital, Rome, Italy

Reference

  1. Sacco S et al (2018) Hormonal contraceptives and risk of ischemic stroke in women with migraine: a consensus statement from the European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESC). J Headache Pain 18:108. https://doi.org/10.1186/s10194-017-0815-1 View ArticleGoogle Scholar

Copyright

© The Author(s). 2018

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate. Please note that comments may be removed without notice if they are flagged by another user or do not comply with our community guidelines.

Advertisement